Literature DB >> 4504035

Encephalopathy in acute leukaemia associated with methotrexate therapy.

H E Kay, P J Knapton, J P O'Sullivan, D G Wells, R F Harris, E M Innes, J Stuart, F C Schwartz, E N Thompson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4504035      PMCID: PMC1648136          DOI: 10.1136/adc.47.253.344

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


× No keyword cloud information.
  17 in total

1.  Effects of folic acid on the mental state and fit-frequency of drug-treated epileptic patients.

Authors:  E H Reynolds
Journal:  Lancet       Date:  1967-05-20       Impact factor: 79.321

2.  EEG studies in children with leukaemia.

Authors:  D M Butcher; R M Hardisty; L Lange; G Pampiglione
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1970-02

3.  Intrathecal methotrexate.

Authors:  K D Bagshawe; I T Magrath; P R Golding
Journal:  Lancet       Date:  1969-12-06       Impact factor: 79.321

4.  Intrathecal methotrexate.

Authors:  F Rosner; S L Lee; M Kagen; A N Morrison
Journal:  Lancet       Date:  1970-01-31       Impact factor: 79.321

5.  Intrathecal methotrexate.

Authors:  G Pasquinucci; R Pardini; F Fedi
Journal:  Lancet       Date:  1970-02-07       Impact factor: 79.321

6.  Death after intrathecal methotrexate.

Authors:  E H Back
Journal:  Lancet       Date:  1969-11-08       Impact factor: 79.321

7.  Active immunotherapy in treatment of acute leukaemia.

Authors:  R J Guyer; D Crowther
Journal:  Br Med J       Date:  1969-11-15

8.  Dementia and folate deficiency.

Authors:  R W Strachan; J G Henderson
Journal:  Q J Med       Date:  1967-04

9.  Pulmonary disease complicating intermittent therapy with methotrexate.

Authors:  A M Clarysse; W J Cathey; G E Cartwright; M M Wintrobe
Journal:  JAMA       Date:  1969-09-22       Impact factor: 56.272

10.  Hepatotoxic effects of methotrexate.

Authors:  E M Hersh; V G Wong; E S Henderson; E J Freireich
Journal:  Cancer       Date:  1966-04       Impact factor: 6.860

View more
  41 in total

1.  Brain damage after intrathecal methotrexate.

Authors:  B Smith
Journal:  J Neurol Neurosurg Psychiatry       Date:  1975-08       Impact factor: 10.154

Review 2.  Folates and psychiatric disorders. Clinical potential.

Authors:  R Crellin; T Bottiglieri; E H Reynolds
Journal:  Drugs       Date:  1993-05       Impact factor: 9.546

3.  Reversal of CNS-prophylaxis-related leukoencephalopathy after CSF shunting: case histories of identical twins.

Authors:  I H Tekkök; D A Carter; M G Robinson; R Brinker
Journal:  Childs Nerv Syst       Date:  1996-06       Impact factor: 1.475

Review 4.  Clinical features, pathogenesis and management of drug-induced seizures.

Authors:  G Zaccara; G C Muscas; A Messori
Journal:  Drug Saf       Date:  1990 Mar-Apr       Impact factor: 5.606

Review 5.  Atypical MRI findings in treatment-related leukoencephalopathy: case report.

Authors:  Y Ohmoto; K Kajiwara; S Kato; T Nisizaki; H Ito; S Tamura
Journal:  Neuroradiology       Date:  1996-02       Impact factor: 2.804

6.  Neurological complications of childhood leukaemia.

Authors:  R H Campbell; W C Marshall; J M Chessells
Journal:  Arch Dis Child       Date:  1977-11       Impact factor: 3.791

7.  Competitive protein binding assay for methotrexate.

Authors:  C E Myers; M E Lippman; H M Elliot; B A Chabner
Journal:  Proc Natl Acad Sci U S A       Date:  1975-09       Impact factor: 11.205

8.  Treatment of overt meningeal leukaemia in children: results of second MRC meningeal leukaemia trial.

Authors:  M L Willoughby
Journal:  Br Med J       Date:  1976-04-10

9.  Subacute combined degeneration of the cord due to folate deficiency: response to methyl folate treatment.

Authors:  E G Lever; R D Elwes; A Williams; E H Reynolds
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-10       Impact factor: 10.154

10.  Acute leukemia in children: experience in Saskatchewan in 1966-72.

Authors:  J B McSheffrey; A Naidoo; W E Hirte
Journal:  Can Med Assoc J       Date:  1975-08-23       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.